Posts by Christopher
The Patch: Promising Data on Gene Cell Therapy for HIV Cure from Rockville Firm
Original Post in The Patch By: Michael O’Connell American Gene Technologies, a Rockville-based biotech firm, announced on Friday that it was standing up a new company to oversee its HIV treatment project, which recently completed Phase 1 of its clinical trial. “When we did the efficacy part of the Phase 1 trial, we got really encouraging…
Read MoreMy MC Media: Rockville Company Launches Spinoff Focused on Curing HIV
Original Post in MyMCMedia By: Suzanne Pollak American Gene Technologies (AGT) in Rockville is ramping up efforts to develop a possible cure for HIV, announcing Friday it has launched a spinoff company that will focus exclusively on HIV, human immunodeficiency virus. AGT CEO Jeff Galvin explained, “Now we’re launching a new company, Addimmune, to accelerate…
Read MoreMorningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure
Original Post in Morningside Maryland A Rockville-based biotech firm, American Gene Technologies (AGT), has reported promising data on its gene cell therapy for HIV cure. The treatment, which involves genetically modifying a patient’s immune cells to target and eliminate HIV-infected cells, has shown significant promise in early-stage clinical trials. According to AGT, the therapy has…
Read MoreOur Sole Purpose Is to Cure HIV. We Are Addimmune™.
The HIV epidemic has raged for over four decades and to date, there is no widely available cure. However, in rare cases, people living with HIV have been cured. The first cure was declared in 2008, the second in 2019, and then two more in 2022 and another in 2023. These cases shatter the notion…
Read MorePerspectives on HIV: Elite Controllers
Are some people resistant to HIV? Under normal circumstances, exposure to HIV leads to infection, which inevitably leads to AIDS after years of immune destruction by the virus. However, there are certain groups of people that deviate from the norm: A patient can be classified as part of multiple groups at the same time, and…
Read MorePerspectives on HIV: Evolving Treatments
HIV is a breakable mechanism. Human immunodeficiency virus (HIV) is more fragile than you think. In fact, scientists have found multiple pharmaceuticals which can break the viral life cycle. HIV causes a lifelong infection that inevitably leads to AIDS, a potentially lethal condition, so the diversity of anti-HIV medications available provide a life-saving safety net…
Read MoreWhy Hasn’t HIV Been Cured Yet?
The silent HIV epidemic has been ongoing for 4 decades. AIDS-related illnesses have claimed over 32 million lives since the beginning of the HIV epidemic in 1981. The death toll, societal impact, and economic effects of the HIV epidemic have made HIV/AIDS one of the greatest public health threats the world has ever known. Governments,…
Read MoreThe Road to an HIV Cure: Lessons from Hepatitis C
What is a chronic viral infection, and can they be cured? Addimmune is pursuing a functional cure for one of the most notorious human viruses, HIV. Without medical intervention, infection with Human Immunodeficiency Virus (HIV) leads to AIDS, a lethal condition that has claimed millions of lives since the start of the epidemic. Today, HIV…
Read MoreSafety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
This scientific publication in Frontiers in Medicine explores advancements in HIV gene therapy development, with a specific emphasis on the role of lentiviral vectors. As Addimmune, the HIV division of American Gene Technologies, we are closely following research in this field as it significantly informs our own work. The article highlights the potential of lentiviral…
Read More